Literature DB >> 22430321

[Arterial hypertension in patients with coronary artery disease].

T Graf1, H Schunkert.   

Abstract

Arterial hypertension is the most important risk factor for coronary artery disease (CAD). There is a high coincidence of both diseases, whereby both impair coronary microcirculatory function synergistically, which can be measured functionally by decreased coronary flow reserve. This dysfunction leads to permanent damage to the left ventricular myocardium. Lifestyle changes play a central role in the primary and secondary prevention of CAD. Additionally, there are well-established options for antihypertensive drug therapy, which should be combined with aspirin and statins. Pharmacological treatment should follow distinctive blood pressure goals in relation to the severity of CAD. Particular attention is paid in this context to the relation between diastolic blood pressure values and cardiovascular endpoints, which displays a j-shaped curve with the lowest risk at levels between 70 and 90 mmHg.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22430321     DOI: 10.1007/s00059-012-3587-z

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  23 in total

1.  Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention.

Authors:  Clive Rosendorff; Henry R Black; Christopher P Cannon; Bernard J Gersh; Joel Gore; Joseph L Izzo; Norman M Kaplan; Christopher M O'Connor; Patrick T O'Gara; Suzanne Oparil
Journal:  Circulation       Date:  2007-05-14       Impact factor: 29.690

2.  Homogeneously reduced versus regionally impaired myocardial blood flow in hypertensive patients: two different patterns of myocardial perfusion associated with degree of hypertrophy.

Authors:  A Gimelli; J Schneider-Eicke; D Neglia; G Sambuceti; A Giorgetti; G Bigalli; G Parodi; R Pedrinelli; O Parodi
Journal:  J Am Coll Cardiol       Date:  1998-02       Impact factor: 24.094

3.  Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study.

Authors:  D Levy; K M Anderson; D D Savage; W B Kannel; J C Christiansen; W P Castelli
Journal:  Ann Intern Med       Date:  1988-01       Impact factor: 25.391

4.  Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?

Authors:  Franz H Messerli; Giuseppe Mancia; C Richard Conti; Ann C Hewkin; Stuart Kupfer; Annette Champion; Rainer Kolloch; Athanase Benetos; Carl J Pepine
Journal:  Ann Intern Med       Date:  2006-06-20       Impact factor: 25.391

5.  Ischemic heart disease in women.

Authors:  Carl J Pepine
Journal:  J Am Coll Cardiol       Date:  2006-02-07       Impact factor: 24.094

6.  Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.

Authors:  Anushka Patel; S MacMahon; J Chalmers; B Neal; M Woodward; L Billot; S Harrap; N Poulter; M Marre; M Cooper; P Glasziou; D E Grobbee; P Hamet; S Heller; L S Liu; G Mancia; C E Mogensen; C Y Pan; A Rodgers; B Williams
Journal:  Lancet       Date:  2007-09-08       Impact factor: 79.321

7.  Effect of antecedent hypertension and follow-up blood pressure on outcomes after high-risk myocardial infarction.

Authors:  Jens J Thune; James Signorovitch; Lars Kober; Eric J Velazquez; John J V McMurray; Robert M Califf; Aldo P Maggioni; Jean L Rouleau; Jonathan Howlett; Steven Zelenkofske; Marc A Pfeffer; Scott D Solomon
Journal:  Hypertension       Date:  2007-11-19       Impact factor: 10.190

8.  Reduction of coronary reserve: a mechanism for angina pectoris in patients with arterial hypertension and normal coronary arteries.

Authors:  D Opherk; G Mall; H Zebe; F Schwarz; E Weihe; J Manthey; W Kübler
Journal:  Circulation       Date:  1984-01       Impact factor: 29.690

9.  Explaining the decrease in U.S. deaths from coronary disease, 1980-2000.

Authors:  Earl S Ford; Umed A Ajani; Janet B Croft; Julia A Critchley; Darwin R Labarthe; Thomas E Kottke; Wayne H Giles; Simon Capewell
Journal:  N Engl J Med       Date:  2007-06-07       Impact factor: 91.245

10.  The first hypertension trial comparing the effects of two fixed-dose combination therapy regimens on cardiovascular events: Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH).

Authors:  Kenneth A Jamerson
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 Jul-Aug       Impact factor: 3.738

View more
  1 in total

1.  Relationship between C-reactive protein/albumin ratio and coronary artery disease severity in patients with stable angina pectoris.

Authors:  Yavuz Karabağ; Metin Çağdaş; Ibrahim Rencuzogullari; Süleyman Karakoyun; İnanç Artaç; Doğan İliş; Eray Atalay; Mahmut Yesin; Mustafa Ozan Gürsoy; Ibrahim Halil Tanboğa
Journal:  J Clin Lab Anal       Date:  2018-04-18       Impact factor: 2.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.